Is Cohen & Steers, Inc. (CNS) a Buy, Sell, or Hold?
NYSE : CNS
Cohen & Steers, Inc.
$84.65 USD
$3.58 (4.42%)
- Volume
- 438.65K
- Average Volume
- 296.93K
- Market Capitalization
- $4.35B
- P/E Ratio
- 27.94
- Dividend Yield
- 3.05%
- Price Target
- $84.00
- Year High
- $84.93
- Year Low
- $58.39
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.83
- Current Ratio
- $9.86
Company Overview
NYSE
Joseph Martin Harvey
Asset Management
Financial Services
CNS
424
US
USD
Liquidity Metrics
0.24
9.86
9.86
3.69
0.83
Sales & Valuation
$567.8M
7.57
7.73
-339.38
-0.25
Profitability
$2.98
$153.22M
27.12%
36.35%
30.54%
19.69%
P/E Metrics
27.94
9.87
9.87
Analyst Price Target & Rating
$84.00
$84.00
$84.00
4/5
13 Analysts
0.77%
Poll Results
About Cohen & Steers, Inc. (NYSE:CNS) Stock
Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity ... and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources. Preferred securities also constitute a part of its fixed income portfolios. Established in 1986, Cohen & Steers, Inc. maintains its primary base in New York, with international branch offices in London (UK), Central (Hong Kong), Tokyo (Japan), and Seattle (Washington).
Cohen & Steers Q2: Rally Reflects Improving Real Estate Flows (Downgrade)
2026-07-17 13:31:22
Cohen & Steers, Inc. is now rated Hold after a strong rally closed the prior valuation gap. CNS's Q2 saw net inflows of $1.3B and AUM rise to $100.1B, signaling renewed interest in public real estate. Operating margin expanded to 36.3% on revenue growth, with scope to reach 37% in H2 if markets remain stable.
Cohen & Steers, Inc. (CNS) Q2 2026 Earnings Call Transcript
2026-07-17 13:16:20
Cohen & Steers, Inc. (CNS) Q2 2026 Earnings Call Transcript
Cohen & Steers Q2 Earnings Call Highlights
2026-07-17 11:04:18
Cohen & Steers NYSE: CNS reported higher second-quarter 2026 adjusted earnings and assets under management, as executives pointed to improving demand for real estate, infrastructure, preferred securities and broader real assets strategies.
COHEN & STEERS REPORTS RESULTS FOR SECOND QUARTER 2026
2026-07-16 16:34:00
NEW YORK, July 16, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the quarter ended June 30, 2026. The earnings release along with the accompanying earnings presentation can be viewed at Cohen & Steers Reports Results for Second Quarter 2026 and on the company's website at www.cohenandsteers.com under "Company—Investor Relations—Earnings Archive.
2026-07-16 09:00:00
NEW YORK, July 16, 2026 /PRNewswire/ -- Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") today announced the results of its transferable rights offering (the "Offer"), which commenced on June 18, 2026 and expired on July 15, 2026 (the "Expiration Date"). The Offer was led by UBS Investment Bank as the sole dealer manager.
2026-07-14 07:30:00
Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring
2026-07-14 07:00:00
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders, today announced results from a new healthcare claims study of treatment patterns of newly diagnosed and established GAD patients, including pharmacotherapy use, discontinuation, switching and treatment progression. The fi.
Cohen & Steers: Diversification From Mag 7
2026-07-13 15:32:13
Cohen & Steers, Inc. (CNS) is rated BUY, driven by strong fund inflows, accelerating REIT performance, and a 37% forward P/E discount versus historical peaks. Cohen & Steers' AUM reached $93 billion in Q1 2026, with 86% of AUM outperforming benchmarks over one year and 98% over three years. REITs, comprising 48% of AUM, are benefiting from sector rotation, improved property fundamentals, and have delivered double-digit YTD returns.
Frequently Asked Questions
-
What is the current Cohen & Steers, Inc. (CNS) stock price?
-
Cohen & Steers, Inc.(NYSE:CNS) stock price is $84.65 in the last trading session. During the trading session, CNS stock reached the peak price of $84.93 while $58.39 was the lowest point it dropped to. The percentage change in CNS stock occurred in the recent session was 4.42% while the dollar amount for the price change in CNS stock was $3.58.
-
CNS's industry and sector of operation?
-
The NYSE listed CNS is part of Asset Management industry that operates in the broader Financial Services sector.
-
Who are the executives of CNS?
-
Francis Casimir Poli | Executive Vice President, General Counsel & Secretary
Jon Young Cheigh | President & Chief Investment Officer
Douglas Bond | Executive VP, Head of Closed End Funds & Portfolio Manager
Joseph Harvey | Chief Executive Officer & Director
James Corl | Executive Vice President & Head of Private Real Estate -
How many employees does CNS have?
-
Number of CNS employees currently stands at 424. CNS operates from 1166 Avenue of the Americas, New York City, NY 10017, US.
-
Link for CNS official website?
-
Official Website of CNS is: https://www.cohenandsteers.com
-
How do I contact CNS?
-
CNS could be contacted at phone #800 330 7348 and can also be accessed through its website. CNS operates from 1166 Avenue of the Americas, New York City, NY 10017, US.
-
How many shares of CNS are traded daily?
-
The average number of CNS shares traded daily for last 3 months was 296.93K.
-
What is the market cap of CNS currently?
-
The market value of CNS currently stands at $4.35B with its latest stock price at $84.65